The management of Molecule 77 has announced that it is seeking additional funding for clinical studies and patent in process may increase value and required investment up to double the initial round.

An acquisition or partnership in its IP may also be considered.

For more information, please contact the company.

Contact

We have isolated a cannabinoid-based healing compound that can

• accelerate healing of fractures
• restore lost productivity due to incapacitation
• promote mental health accompanying traumatic injuries, including PTSD, anxiety and post-traumatic depression

Adjacent image shows healing in progress in fractured rodent limb. Click-tap for larger view.

Estimated potential market size: $200 billion annually worldwide.